Oral Health Study for Children With Beta-Thalassemia
Part of Blood & lymphatic, Mouth & dental clinical trials.
This study looks at how beta-thalassemia (a blood disorder) affects children's teeth and gums. Researchers want to understand oral health challenges in affected children to help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has been diagnosed with beta-thalassemia major (confirmed in medical records)
- Your child is between 8 and 10 years old
- Your child can cooperate during the study visit (able to sit still and follow simple instructions)
- Your child does not have significant cognitive impairment that would prevent participation
- Your child has not been in another oral health study or education program in the past 6 months
- Your child's medical condition is stable (not in active crisis or severe illness)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how severe thalassemia is in children and teens. If your child has thalassemia and is between 18 months and 18 years old, joining may help doctors better understand the condition.
This study checks how well children with beta thalassemia stick to their daily oral chelation pill (deferasirox). It aims to find ways to help them take it more regularly, improving iron control and reducing complications.
This study is for people with beta-thalassemia who have already received the gene therapy betibeglogene autotemcel (beti-cel). It collects information to learn how patients are doing after this treatment in real-world settings.
This study looks at what factors might affect growth in children with beta-thalassemia major who get regular blood transfusions. It aims to help understand and manage growth problems better.
This study tests whether motivational interviewing, a type of counseling, helps people with thalassemia take their medications more regularly and feel more confident in managing their health. If you are an adult with thalassemia who needs regular blood transfusions and takes iron chelation therapy, this trial might be for you.
This trial tests a new gene therapy (BD211) for children and teens with severe beta-thalassemia who need regular blood transfusions. The treatment uses your own blood stem cells, modified with a working gene, to help your body make healthy red blood cells and reduce the need for transfusions.
Hear when a new B Thalassemia Major trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.